SEATTLE, Feb. 28, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article and exclusive CEO video interview covering Chemesis International Inc.'s (CSE: CSI) (OTCQB: CADMF) (FRA: CWAA) development of cannabis operations in Colombia. Chemesis owns a licensed cultivator there, growing on more than a thousand acres as well as in a 10,000 sqft greenhouse. The company is also building a GMP-certified production lab and extraction facility in Bogota with an eye toward both the Colombian domestic and the international export markets.
Chemesis International CEO Edgar Montero discusses the company’s operations in Colombia and its presence in Puerto Rico, among other things, in Part II of CFN Media’s exclusive interview. Please use this link to see the interview: https://www.cannabisfn.com/cfnvideo/?id=A7AAqZqu. Here is a link to Part I, where Mr. Montero focuses on the company’s California production, fulfillment and distribution operations as well as its brand partnership with Jay and Silent Bob: https://www.cannabisfn.com/cfnvideo/?id=0Hy9eKzR.
Cannabis industry research firm Prohibition Partners anticipates the legal cannabis industry in Latin America will reach $12.7 billion in annual sales by 2028. Uruguay led the way in the legalization movement, making recreational cannabis legal in 2013. No other countries have made that step, but several have legalized medical programs in the years since. Still, Colombia is currently the only country whose government is aggressively promoting cannabis exports, making that country the current hot spot for cannabis development.
Please click here to follow Chemesis' corporate developments.
Colombia’s Advantages
In early 2018, the Colombian government’s Drug Control Fund authorized the harvest of up to 40.5 tons of medical marijuana for export purposes. The agency estimates that at full capacity, the country could supply about 44% of the world’s current demand for medical marijuana products. The program is just getting off the ground, however, and the country is a long way from reaching that production level.
The combination of a government-directed focus on exports, an ideal growing climate, and very low cost of production makes Colombia a crucial focus for near-term development. The country also boasts a population of about 6 million medical marijuana patients. One interesting aspect of the country’s laws is the general prohibition on the sale of cannabis flower. Companies operating there are necessarily focused on oils and extracted products, areas of the market that offer higher margins and are generally more attractive to consumers anyway.
Please click here to follow Chemesis' corporate developments.
Chemesis’ Colombian Operations
Chemesis has been working closely with the Colombian government since acquiring subsidiary La Finca Interacviva-Archna Med SAS to expand its existing licensed operations in the country. La Finca is currently licensed to cultivate, produce extracted products, and distribute those products domestically. La Finca is a founding member of Colombia’s Association for the Promotion of Hemp Growing, and has established relationships with over 2,000 farming families throughout the country. It is partnered with Colombia’s largest university for research and development, and is involved in farmer education programs across the country.
La Finca currently offers cannabinoid-based cosmetic products and is expanding its product lines as the company grows. La Finca anticipates achieving export capabilities upon completion of its GMP-certified production facility in Bogota, opening up a much wider market for its derivative product lines.
Looking Ahead
Colombia recently announced a renewed focus on prosecuting the cannabis black market in the country, which has only solidified the country’s legal medical program. That program is just finding its legs, and many companies establishing operations there are kind of building from scratch in a market still in its infancy. By acquiring La Finca, a company that has been operational in Colombia since 2017 and has extensive relationships throughout the country, Chemesis has positioned itself as a strong early mover in what could prove to be an international hub of low cost, high quality, high volume production for the international cannabis market.
Investors may want to keep an eye out for Colombian developments as the company also expands its existing operations in the California and Puerto Rico markets. Chemesis’ focus on cannabis extracts and derived products in key markets looks promising as demand rises across the globe.
Please click here to follow Chemesis' corporate developments.
Please follow the link to see the interview and read the full article: https://www.cannabisfn.com/chemesis-in-colombia-the-place-to-be-for-south-american-cannabis-plus-exclusive-ceo-interview/
About CFN Media
For Visitors and Viewers
CFN Media’s Cannabis Financial Network (CannabisFN.com) is the destination for savvy investors and business people profiting from the worldwide cannabis industry. Viewers will see breaking news, exclusive content and original programming involving the people, companies and investments shaping the industry.
For Cannabis Businesses & Companies
CFN Media is a leading agency and financial media network dedicated to the cannabis industry. We help private, pre-public and public cannabis companies in the US and Canada attract capital, investors and media attention.
Our powerful digital media and distribution platform conveys a company’s message and value proposition directly to accredited and retail investors and national media active in the North American cannabis markets.
Since 2013, CFN Media has enabled the world’s preeminent cannabis companies to thrive in the capital and public markets.
Learn how to become a CFN Media client company, brand or entrepreneur: http://www.cannabisfn.com/featuredcompany
Disclaimer
CannabisFN.com is not an independent financial investment advisor or broker-dealer. You should always consult with your own independent legal, tax, and/or investment professionals before making any investment decisions. The information provided on http://www.cannabisfn.com (the ‘Site’) is either original financial news or paid advertisements drafted by our in-house team or provided by an affiliate. CannabisFN.com, a financial news media and marketing firm enters into media buys or service agreements with the companies that are the subject of the articles posted on the Site or other editorials for advertising such companies. We are not an independent news media provider. We make no warranty or representation about the information including its completeness, accuracy, truthfulness or reliability and we disclaim, expressly and implicitly, all warranties of any kind, including whether the Information is complete, accurate, truthful, or reliable. As such, your use of the information is at your own risk. Nor do we undertake any obligation to update the items posted. CannabisFN.com received compensation for producing and presenting high quality and sophisticated content on CannabisFN.com along with financial and corporate news.
The above article is sponsored content. Emerging Growth LLC, which owns CannabisFN.com and CFN Media, has been hired to create awareness. Please follow the link below to view our full disclosure outlining our compensation: http://www.cannabisfn.com/legal-disclaimer/
Frank Lane
206-369-7050
flane@cannabisfn.com